AGP

Artia Global Partners Portfolio holdings

AUM $389M
This Quarter Return
+5.68%
1 Year Return
+34.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$249M
AUM Growth
+$249M
Cap. Flow
-$16.9M
Cap. Flow %
-6.79%
Top 10 Hldgs %
79.38%
Holding
36
New
10
Increased
6
Reduced
7
Closed
2

Top Buys

1
BIIB icon
Biogen
BIIB
$13.9M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
$8.78M
3
MRK icon
Merck
MRK
$6.92M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$3.64M
5
AZN icon
AstraZeneca
AZN
$1.7M

Top Sells

1
LLY icon
Eli Lilly
LLY
$26.6M
2
ARGX icon
argenx
ARGX
$18.2M
3
NVO icon
Novo Nordisk
NVO
$7.96M
4
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
$2.46M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$2.43M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
WAT icon
26
Waters Corp
WAT
$18B
$881K 0.33%
2,845
– –
PCVX icon
27
Vaxcyte
PCVX
$4B
$853K 0.32%
+22,759
New +$853K
TYRA icon
28
Tyra Biosciences
TYRA
$675M
$727K 0.27%
+45,253
New +$727K
AMRN
29
Amarin Corp
AMRN
$311M
$385K 0.14%
+256,800
New +$385K
AMLX icon
30
Amylyx Pharmaceuticals
AMLX
$836M
$245K 0.09%
8,339
-15,544
-65% -$456K
LEGN icon
31
Legend Biotech
LEGN
$6.41B
$241K 0.09%
+5,000
New +$241K
LRMR icon
32
Larimar Therapeutics
LRMR
$310M
$172K 0.06%
+38,057
New +$172K
ALT icon
33
Altimmune
ALT
$338M
– –
0
– –
KYMR icon
34
Kymera Therapeutics
KYMR
$2.95B
– –
-30,000
Closed -$749K
SRPT icon
35
Sarepta Therapeutics
SRPT
$1.78B
– –
0
– –
RXDX
36
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
– –
-22,321
Closed -$2.46M
1
2